Catalyst Wire Dossier Catalyst Wire Dossier

Reverse Genetic H9N2 Influenza Vaccine

Reverse Genetic H9N2 Influenza Vaccine · Alachua Government Services, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Reverse Genetic H9N2 Influenza Vaccine, covering 2023-02-16 to 2023-02-16. Get the full timeline:

Most recent: Clinical Trial Update: Reverse Genetic H9N2 Influenza Vaccine Study in Adults [Phase 1, Phase 2]

See pricing